Report Abstract
A throrough review of pharamceutical current good manufacturing practices from 2006
through 2009 provides insight into regulatory risks associated with pharmaceutical product manufacturing. This information
may be used to:
- Evaluate and review risks for pharmaceutical
manufacturing.
- Develop effective strategies for managing
pharmaceutical operations.
- Ensure proper manufacturing
support systems compliance.
- Monitor and report information
regarding pharmaceutical manufacturing regulatory risk
Pharmaceutical
manufacturers must manage regulatory risk to ensure products are developed in a manner consistent with organizational goals
and strategic objectives. Ongoing operations and marketplace supply can be hindered
if a producer is not keenly aware of the regulatory environment and potential risks of underperforming processes. Organizational
risk management may become a competitive adavantage for pharmaceutical manufacturers when applied in a way that ensures compliance
and supports operational/production needs of the pharmaceutical manufacturer. This report will address the regulatory risk
of Current Good Manufacturing Practices (cGMP's) through.....
Report is 23 pages of value added, informative compliance information. Price $125.00.
